Consistent with this result, the expression of the inflammatory factors IL-6 and Cxcl1 was significantly reduced after Ganweikang tablet treatment, while the expression of IL-4 (anti-inflammatory cytokine) was significantly increased in either NAFL or NASH liver (Figure 7B and Supplementary Figure S1B). The gene discussed is CXCL1; the disease is metabolic dysfunction-associated steatohepatitis.